Progress in the development of a cervical cancer vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progress in the development of a cervical cancer vaccine

Published:2006-01 Issue:3 Volume:2 Page:259-269
ISSN:1176-6336
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:Therapeutics and Clinical Risk Management

Author:

Winters Ursula,Roden Richard,Kitchener Henry,Stern Peter

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Reference63 articles.

1. Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

2. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

3. Vaccination of Cattle with the N-Terminus of L2 Is Necessary and Sufficient for Preventing Infection by Bovine Papillomavirus-4

4. Therapeutic Vaccination with MVA E2 Can Eliminate Precancerous Lesions (CIN 1, CIN 2, and CIN 3) Associated with Infection by Oncogenic Human Papillomavirus

5. Management of women who test positive for high-risk types of human papillomavirus: the HART study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications;Research Journal of Pharmacy and Technology;2022-06-28

2. Comparing cytosolic expression to peroxisomal targeting of the chimeric L1/L2 (ChiΔH-L2) gene from human papillomavirus type 16 in the methylotrophic yeasts Pichia pastoris and Hansenula polymorpha;Yeast;2012-08-28

3. Implementing HPV Vaccines: Public Knowledge, Attitudes, and the Need for Education;International Quarterly of Community Health Education;2011-01

4. HPV Cervical Infection and Immunodysregulation: Synergistic Risks for Neoplasia-Review;Current Women's Health Reviews;2010-11-01

5. A novel mitogen fusion protein against CD40+ cells with potent vaccine adjuvant properties;Vaccine;2010-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3